IL142908A0 - Compounds useful in the treatment of inflammatory diseases - Google Patents
Compounds useful in the treatment of inflammatory diseasesInfo
- Publication number
- IL142908A0 IL142908A0 IL14290899A IL14290899A IL142908A0 IL 142908 A0 IL142908 A0 IL 142908A0 IL 14290899 A IL14290899 A IL 14290899A IL 14290899 A IL14290899 A IL 14290899A IL 142908 A0 IL142908 A0 IL 142908A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- inflammatory diseases
- compounds useful
- compounds
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828074.6A GB9828074D0 (en) | 1998-12-18 | 1998-12-18 | Therapeutically useful compounds |
| PCT/EP1999/010000 WO2000037444A1 (en) | 1998-12-18 | 1999-12-16 | Compounds useful in the treatment of inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142908A0 true IL142908A0 (en) | 2002-04-21 |
Family
ID=10844608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14290899A IL142908A0 (en) | 1998-12-18 | 1999-12-16 | Compounds useful in the treatment of inflammatory diseases |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6867192B1 (pt) |
| EP (1) | EP1140837B1 (pt) |
| JP (1) | JP4431282B2 (pt) |
| KR (1) | KR20010101258A (pt) |
| CN (1) | CN1330637A (pt) |
| AR (1) | AR023727A1 (pt) |
| AT (1) | ATE273954T1 (pt) |
| AU (1) | AU760169B2 (pt) |
| BR (1) | BR9916282A (pt) |
| CA (1) | CA2355630A1 (pt) |
| CO (1) | CO5170533A1 (pt) |
| CZ (1) | CZ20012209A3 (pt) |
| DE (1) | DE69919580T2 (pt) |
| ES (1) | ES2226488T3 (pt) |
| GB (1) | GB9828074D0 (pt) |
| GT (1) | GT199900217A (pt) |
| HK (1) | HK1038744A1 (pt) |
| HU (1) | HUP0104867A3 (pt) |
| IL (1) | IL142908A0 (pt) |
| NO (1) | NO20012995L (pt) |
| NZ (1) | NZ511478A (pt) |
| PE (1) | PE20001387A1 (pt) |
| PL (1) | PL348059A1 (pt) |
| TR (1) | TR200101709T2 (pt) |
| WO (1) | WO2000037444A1 (pt) |
| ZA (1) | ZA200103948B (pt) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ518886A (en) | 1999-12-28 | 2004-02-27 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| GB0014892D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014883D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014851D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014869D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014849D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014881D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0127423D0 (en) * | 2001-11-15 | 2002-01-09 | Glaxo Group Ltd | Process |
| GB0218630D0 (en) | 2002-08-10 | 2002-09-18 | Tanabe Seiyaku Co | Novel compounds |
| WO2004103967A2 (en) | 2003-05-20 | 2004-12-02 | Genentech, Inc. | Thiocarbamate inhibitors of alpha-4 integrins |
| EP3130349A1 (en) | 2004-06-04 | 2017-02-15 | Genentech, Inc. | Method for treating multiple sclerosis |
| US8159428B2 (en) | 2005-02-23 | 2012-04-17 | Pixtronix, Inc. | Display methods and apparatus |
| US7742016B2 (en) | 2005-02-23 | 2010-06-22 | Pixtronix, Incorporated | Display methods and apparatus |
| US8519945B2 (en) | 2006-01-06 | 2013-08-27 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US7999994B2 (en) | 2005-02-23 | 2011-08-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US8310442B2 (en) | 2005-02-23 | 2012-11-13 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US9082353B2 (en) | 2010-01-05 | 2015-07-14 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US9261694B2 (en) | 2005-02-23 | 2016-02-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US9158106B2 (en) | 2005-02-23 | 2015-10-13 | Pixtronix, Inc. | Display methods and apparatus |
| US8482496B2 (en) | 2006-01-06 | 2013-07-09 | Pixtronix, Inc. | Circuits for controlling MEMS display apparatus on a transparent substrate |
| US20070205969A1 (en) | 2005-02-23 | 2007-09-06 | Pixtronix, Incorporated | Direct-view MEMS display devices and methods for generating images thereon |
| US9229222B2 (en) | 2005-02-23 | 2016-01-05 | Pixtronix, Inc. | Alignment methods in fluid-filled MEMS displays |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| US8526096B2 (en) | 2006-02-23 | 2013-09-03 | Pixtronix, Inc. | Mechanical light modulators with stressed beams |
| US9176318B2 (en) * | 2007-05-18 | 2015-11-03 | Pixtronix, Inc. | Methods for manufacturing fluid-filled MEMS displays |
| TW201014605A (en) | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
| US8169679B2 (en) | 2008-10-27 | 2012-05-01 | Pixtronix, Inc. | MEMS anchors |
| WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
| EP2531881A2 (en) | 2010-02-02 | 2012-12-12 | Pixtronix Inc. | Methods for manufacturing cold seal fluid-filled display apparatus |
| BR112012019383A2 (pt) | 2010-02-02 | 2017-09-12 | Pixtronix Inc | Circuitos para controlar aparelho de exibição |
| WO2013101771A2 (en) | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| SG11201404486QA (en) | 2012-01-31 | 2014-11-27 | Genentech Inc | Anti-ig-e m1' antibodies and methods using same |
| US9134552B2 (en) | 2013-03-13 | 2015-09-15 | Pixtronix, Inc. | Display apparatus with narrow gap electrostatic actuators |
| RU2016152499A (ru) * | 2014-05-30 | 2018-07-04 | Драг Дискавери Ресеч Сентэ | Новые соединения в качестве противотуберкулезных препаратов |
| RU2018103940A (ru) | 2015-07-08 | 2019-08-08 | Аксеровижн, Инк. | Фармацевтические композиции, содержащие антагонист интегрина альфа4, для применения в лечении воспалительных состояний глаза |
| KR20180075537A (ko) | 2015-10-06 | 2018-07-04 | 제넨테크, 인크. | 다발성 경화증을 치료하기 위한 방법 |
| SI3464336T1 (sl) * | 2016-06-01 | 2022-06-30 | Athira Pharma, Inc. | Spojine |
| CN109722455B (zh) * | 2017-10-31 | 2022-03-11 | 中国科学院天津工业生物技术研究所 | 微生物发酵生产谷内酯的方法、工程菌及应用 |
| WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| WO2020092375A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
| EP3873900A1 (en) | 2018-10-30 | 2021-09-08 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
| EP3873897B1 (en) | 2018-10-30 | 2024-08-14 | Gilead Sciences, Inc. | N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases |
| US11179383B2 (en) | 2018-10-30 | 2021-11-23 | Gilead Sciences, Inc. | Compounds for inhibition of α4β7 integrin |
| CN114222730B (zh) | 2019-08-14 | 2024-09-10 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
| CN116670116A (zh) * | 2020-10-21 | 2023-08-29 | 阿祖拉眼科有限公司 | 用于治疗眼部病症的化合物和方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1593858A1 (de) | 1967-03-02 | 1970-10-29 | Hoechst Ag | Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten |
| US4105602A (en) | 1975-02-10 | 1978-08-08 | Armour Pharmaceutical Company | Synthesis of peptides with parathyroid hormone activity |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| JP2002512625A (ja) | 1997-05-29 | 2002-04-23 | メルク エンド カンパニー インコーポレーテッド | 細胞接着阻害薬としての複素環アミド化合物 |
| WO1998053818A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
| DE69833654T2 (de) * | 1997-05-29 | 2006-12-14 | Merck & Co., Inc. (A New Jersey Corp.) | Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren |
| AU7667498A (en) | 1997-05-30 | 1998-12-30 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
-
1998
- 1998-12-18 GB GBGB9828074.6A patent/GB9828074D0/en not_active Ceased
-
1999
- 1999-12-15 CO CO99078241A patent/CO5170533A1/es not_active Application Discontinuation
- 1999-12-15 AR ARP990106429A patent/AR023727A1/es not_active Application Discontinuation
- 1999-12-16 US US09/868,395 patent/US6867192B1/en not_active Expired - Lifetime
- 1999-12-16 WO PCT/EP1999/010000 patent/WO2000037444A1/en not_active Application Discontinuation
- 1999-12-16 JP JP2000589516A patent/JP4431282B2/ja not_active Expired - Lifetime
- 1999-12-16 DE DE69919580T patent/DE69919580T2/de not_active Expired - Lifetime
- 1999-12-16 ES ES99964583T patent/ES2226488T3/es not_active Expired - Lifetime
- 1999-12-16 CN CN99814654A patent/CN1330637A/zh active Pending
- 1999-12-16 CA CA002355630A patent/CA2355630A1/en not_active Abandoned
- 1999-12-16 PL PL99348059A patent/PL348059A1/xx not_active Application Discontinuation
- 1999-12-16 NZ NZ511478A patent/NZ511478A/en unknown
- 1999-12-16 HU HU0104867A patent/HUP0104867A3/hu unknown
- 1999-12-16 BR BR9916282-2A patent/BR9916282A/pt not_active IP Right Cessation
- 1999-12-16 PE PE1999001274A patent/PE20001387A1/es not_active Application Discontinuation
- 1999-12-16 AT AT99964583T patent/ATE273954T1/de not_active IP Right Cessation
- 1999-12-16 EP EP99964583A patent/EP1140837B1/en not_active Expired - Lifetime
- 1999-12-16 CZ CZ20012209A patent/CZ20012209A3/cs unknown
- 1999-12-16 AU AU30391/00A patent/AU760169B2/en not_active Ceased
- 1999-12-16 IL IL14290899A patent/IL142908A0/xx unknown
- 1999-12-16 KR KR1020017007579A patent/KR20010101258A/ko not_active Application Discontinuation
- 1999-12-16 TR TR2001/01709T patent/TR200101709T2/xx unknown
- 1999-12-17 GT GT199900217A patent/GT199900217A/es unknown
-
2001
- 2001-05-15 ZA ZA200103948A patent/ZA200103948B/en unknown
- 2001-06-15 NO NO20012995A patent/NO20012995L/no not_active Application Discontinuation
-
2002
- 2002-01-09 HK HK02100145.2A patent/HK1038744A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69919580T2 (de) | 2005-09-01 |
| ATE273954T1 (de) | 2004-09-15 |
| PE20001387A1 (es) | 2000-12-22 |
| ES2226488T3 (es) | 2005-03-16 |
| US6867192B1 (en) | 2005-03-15 |
| CA2355630A1 (en) | 2000-06-29 |
| AR023727A1 (es) | 2002-09-04 |
| NO20012995L (no) | 2001-08-15 |
| NZ511478A (en) | 2003-08-29 |
| WO2000037444A1 (en) | 2000-06-29 |
| PL348059A1 (en) | 2002-05-06 |
| CN1330637A (zh) | 2002-01-09 |
| JP4431282B2 (ja) | 2010-03-10 |
| DE69919580D1 (de) | 2004-09-23 |
| TR200101709T2 (tr) | 2001-12-21 |
| AU3039100A (en) | 2000-07-12 |
| GB9828074D0 (en) | 1999-02-17 |
| HUP0104867A3 (en) | 2002-06-28 |
| EP1140837A1 (en) | 2001-10-10 |
| BR9916282A (pt) | 2001-10-02 |
| CO5170533A1 (es) | 2002-06-27 |
| EP1140837B1 (en) | 2004-08-18 |
| GT199900217A (es) | 2001-06-09 |
| KR20010101258A (ko) | 2001-11-14 |
| ZA200103948B (en) | 2002-11-15 |
| AU760169B2 (en) | 2003-05-08 |
| CZ20012209A3 (cs) | 2001-09-12 |
| JP2002533326A (ja) | 2002-10-08 |
| NO20012995D0 (no) | 2001-06-15 |
| HUP0104867A2 (hu) | 2002-04-29 |
| HK1038744A1 (zh) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142908A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
| IL132318A0 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
| IL155092A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
| ZA983452B (en) | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. | |
| IL133766A0 (en) | 2-substituted imidazoles useful in the treatment of inflammatory diseases | |
| PL362711A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| GB0106183D0 (en) | Improvements in or relating to the treatment of lesions | |
| EP0777474A4 (en) | METHOD FOR TREATING INFLAMMABLE JOINT DISEASES | |
| AU2002233928A1 (en) | Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases | |
| IL133088A0 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
| GB9816234D0 (en) | Compounds for use in the treatment of inflammation | |
| IL155174A0 (en) | Methods and compositions for the treatment of inflammatory diseases | |
| IL133089A0 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
| AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| IL138654A0 (en) | Methods and materials for treating inflammatory diseases | |
| TW371925U (en) | Structure of the caster | |
| GB9816349D0 (en) | The treatment of inflammatory disorders | |
| GB9816352D0 (en) | The treatment of inflammatory disorders | |
| AU2002300624A1 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
| EP1121118A4 (en) | FORMAMIDE-BASED THERAPEUTIC AGENTS | |
| SI0966447T1 (en) | Small molecules useful in the treatment of inflammatory disease | |
| AU2002306210A1 (en) | 2-substituted imidazoles useful in the treatment of inflammatory diseases | |
| GB9421116D0 (en) | Treatment of inflammatory dermatoses | |
| GB9813109D0 (en) | Treatment of inflammatory skin conditions |